Steroid Management in Patients Undergoing Surgery for IBD


P (patients)

I (intervention)

C (comparator)

O (outcomes)

Steroid-treated patients with or without IBD undergoing colorectal or non-colorectal surgery

Low-dose perioperative steroids

High-dose or stress-dose perioperative steroids

Perioperative hemodynamic instability, adrenal insufficiency, morbidity, mortality, infectious complications

Patients with or without IBD, previously treated with steroids within 1 year undergoing colorectal or non-colorectal surgery

No corticosteroids

High-dose or stress-dose perioperative steroids

Perioperative hemodynamic instability, adrenal insufficiency, morbidity, mortality, infectious complications





Results


Over the years, several studies have been performed to assess the clinical utility and optimal dose of perioperative corticosteroids in steroid-treated patients undergoing surgery (Table 9.2). Initial studies challenging the concept of stress-dose steroids were performed in an era where there were serious concerns about operative wound healing. In these studies, patients underwent surgery without any perioperative steroids, and clinical parameters and HPA function were evaluated. In 1962, Solem and Lund reported 30 patients whose steroids had been stopped more than 4 weeks before surgery undergoing various surgical procedures (IBD undergoing major colorectal surgery, n = 4) without perioperative steroid cover and showed no impending hemodynamic collapse with this management [9]. Two studies investigated patients on steroids at the time of surgery who were operated on without perioperative steroids, measured HPA axis testing and clinical parameters. Hypotension attributed to AI occurred in 4 out of 125 patients combined [10, 11].


Table 9.2
Studies evaluating perioperative steroid dosing




























































































































































First author (year)

Patients studied

Intervention

Study design

N

Outcome

Quality of evidence

Solem (1962) [9]

Patients previously treated with steroids/various surgeries (n = 4 IBD/CRS).

No periop steroids

R

30

No unexplained death attributed to AI

Very low

Jasani (1968) [10]

RA/anterior synovectomy

No periop steroids

PO

21 steroid treated vs. 20 controls

1 patient with abnormal preop ACTH had hypotension responsive to steroids.

Very low

Kehlet (1973) [11]

Steroid-treated patients undergoing various major/minor operations

No periop steroids

PO

104

3 patients with hypotension and low cortisol thought to be AI

Low

Knudsen (1981) [13]

IBD/CRS

200 with no periop steroids, 50 received steroids

R

250

11 cases of hypotension treated with steroids/possible AI

Very low

Lloyd (1981) [14]

RA/Orthopedic surgery

Stress-dose vs. usual daily dose.

PO

61

No difference in periop steroid supplementation between the 2 groups

Very low

Symreng (1981) [15]

Various patients (n = 7 IBD, n = 16, CRS)

If impaired ACTH stim test > HC 25 mg IV preop then 100 mg IV/24 h. If normal ACTH stim test: no periop steroids. Return to usual daily dose postop.

PO

14 steroid-treated patients and 8 steroid-naïve controls

No hemodynamic instability

Very low

Bromberg (1991) [16]

Renal transplant patients admitted w/significant physiologic stress

Usual daily dose

PO

40

No unexplained hemodynamic instability

Very low

Bromberg (1995) [17]

Renal transplant patients/various surgeries

Usual daily dose

PO

52

No clinical or laboratory evidence of adrenocortical insufficiency

Very low

Friedman (1995) [18]

Renal-transplant or RA/major orthopedic surgery

Usual daily dose

PO

28

All patients with endogenous adrenal function. No unexplained hemodynamic instability.

Very low

Glowniak (1997) [20]

Various (colorectal n = 2) with positive ACTH stim test

Stress-dose vs. placebo. Return to usual daily dose postop.

RCT

18

No episodes of AI. One in each group with hypotension.

Very low

Thomason (1999) [21]

Organ transplant/gingival surgery

Stress-dose vs. placebo. Return to usual daily dose postop.

RCT

20

No hemodynamic instability

Very low

Mathis (2004) [19]

Organ transplant/lymphocele drainage

Stress-dose vs. no steroid. Return to usual daily dose postop.

R

58

No hypotension, arthralgia, ileus, mental status changes. Blood glucose higher with stress-dose

Very low

Zaghiyan (2011) [24]

IBD/CRS previously on steroids within 1 year

No periop steroids

R

49

No difference in hemodynamic instability

Low

Zaghiyan (2012) [22]

IBD/CRS

HDS vs. LDS

RO

32

No unexplained hemodynamic instability

Very low

Zaghiyan (2012) [23]

IBD/CRS

HDS vs. LDS

R

97

No difference in hemodynamic instability

Moderate

Aytac (2013) [25]

IBD/CRS

Stress-dose vs. usual daily dose

R

235

More tachycardia with stress-dose otherwise no difference in hemodynamic instability

Moderate

Zaghiyan (2014) [26]

IBD/CRS

HDS vs. LDS

RCT

92

Non-inferiority of LDS vs. HDS with respect to postural hypotension; no difference in hemodynamic instability. More infections with HDS.

High


IBD inflammatory bowel disease, CRS colorectal surgery, RA rheumatoid arthritis, ACTH adrenocorticotropic hormone, HDS high-dose steroids, LDS low-dose steroids, R retrospective, PO prospective observational, RO retrospective observational, RCT randomized controlled trial

We recommend that steroid-treated patients undergoing major colorectal surgery be managed with low-dose perioperative steroids in the perioperative period (evidence quality high; strong recommendation)

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Aug 23, 2017 | Posted by in ABDOMINAL MEDICINE | Comments Off on Steroid Management in Patients Undergoing Surgery for IBD

Full access? Get Clinical Tree

Get Clinical Tree app for offline access